Article

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer’s disease

2026-05-15

Abstract excerpt

<title>Abstract</title> <p> Drug repurposing offers a potential strategy to expand treatment options for conditions with limited therapies, but advancing repurposing candidates toward clinical implementation remains a challenge. Large-scale data, together with advanced genetic and epidemiological methods, may help address this gap. Here, we present an integrative digital medicine approach that combines genetical...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e0d2c726-5a71-5456-ab70-5135b362a93c
DOI: 10.21203/rs.3.rs-9518587/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer’s diseaseDOI 10.21203/rs.3.rs-9518587/v1Read

Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer’s diseaseSemantic proximity Read

AlzGPS: A Genome-wide Positioning Systems Platform to Catalyze Multi-omics for Alzheimer’s Therapeutic DiscoverySemantic proximity Read

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseSemantic proximity Read

omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative DiseasesSemantic proximity Read

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read

Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer’s DiseaseSemantic proximity Read

Data-driven discovery of cell-type-directed network-correcting combination therapy for Alzheimer’s diseaseSemantic proximity Read

Integrated phenotypic and proteomic screening identifies top-tier Alzheimer’s disease therapeutic targetsSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discoverySemantic proximity Read

DeepDrug2: A Germline-focused Graph Neural Network Framework for Alzheimer’s Drug Repurposing Validated by Electronic Health RecordsSemantic proximity Read

Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s DiseaseSemantic proximity Read